Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mvise AG | C1V | Nov 15, 2024 | 0.35 | 0.00 |
MVV Energie AG | MVV1 | Nov 15, 2024 | 29.80 | 0.00 |
MWB FAIRTRADE WPHDL.NA ON | MWB0 | Nov 15, 2024 | 3.77 | 0.00 |
Mycronic | MLT | Nov 15, 2024 | 34.96 | -1.41 |
Mydecine Innovations Group Inc | 0NF0 | Nov 15, 2024 | 0.00 | 0.00 |
Myer Holdings Ltd | 30M | Nov 15, 2024 | 0.57 | +4.59 |
Myers Industries, Inc. | MJF | Nov 15, 2024 | 11.20 | -0.89 |
MYHEALTHCHECKED LS -,015 | 0I10 | Nov 15, 2024 | 0.13 | 0.00 |
MYHOTELMATCH EO 1,- | 6GD0 | Nov 15, 2024 | 0.33 | -7.26 |
Mynaric ADR | M0YA | Nov 15, 2024 | 1.13 | -6.61 |
MYNARIC AG NA O.N. | M0YN | Nov 15, 2024 | 4.81 | -0.82 |
Mynd.Ai | WK6 | Nov 15, 2024 | 1.37 | -6.80 |
Myomo Inc. | 0M61 | Nov 15, 2024 | 4.50 | +2.51 |
MYR Group, Inc. | MYP | Nov 15, 2024 | 141.00 | +0.71 |
Myriad Genetics, Inc. | MYD | Nov 15, 2024 | 14.70 | -0.68 |
MYRIAD URANIUM CORP. | C3Q | Nov 15, 2024 | 0.28 | +8.46 |
Mytilineos S.A. | MYH | Nov 15, 2024 | 32.78 | +0.61 |
N Brown Group PLC | BGUA | Nov 15, 2024 | 0.45 | 0.00 |
N4 Pharma plc. | 0GO | Nov 15, 2024 | 0.00 | 0.00 |
Naas Technology ADR | 6RE | Nov 15, 2024 | 2.54 | +3.25 |
Nabaltec AG | NTG | Nov 15, 2024 | 13.65 | -0.37 |
Nabors Industries Ltd | NBI1 | Nov 15, 2024 | 68.50 | -1.44 |
Nabtesco Corp. | 3N8 | Nov 15, 2024 | 14.60 | +0.69 |
Nachi-Fujikoshi Corp. | 8UM | Nov 15, 2024 | 19.10 | -1.55 |
Nacon S.A. | 4AW | Nov 15, 2024 | 0.53 | +0.95 |
Nafco Co | 64E | Nov 15, 2024 | 11.90 | 0.00 |
NAGACORP | N9J | Nov 15, 2024 | 0.35 | +0.57 |
Nagambie Resources Limited | P6C | Nov 15, 2024 | 0.01 | -7.14 |
Nagarro SE | NA9 | Nov 15, 2024 | 90.25 | +2.56 |
NAGASE + CO. LTD | P22 | Nov 15, 2024 | 19.07 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.